loader image
Friday, January 9, 2026
83.4 F
McAllen
- Advertisement -

What happens if you take too much Ozempic or Wegovy?

Health & Lifestyle
2395

Listen to article (english)

Translate to Spanish or other 102 languages!

Poison control centers across the United States are witnessing a concerning increase in inquiries related to semaglutide, an injectable medication used for diabetes management and weight loss. Image for illustration purposes
Poison control centers across the United States are witnessing a concerning increase in inquiries related to semaglutide, an injectable medication used for diabetes management and weight loss. Image for illustration purposes

Medical News Today

- Advertisement -
  • Poison control centers across the United States are witnessing a concerning increase in inquiries related to semaglutide, an injectable medication used for diabetes management and weight loss.
  • Reports of inadvertent overdoses have led to hospitalizations in some cases, with symptoms including intense nausea, vomiting and abdominal discomfort.
  • Data from America’s Poison Centers reveals a startling 15-fold increase in semaglutide-related calls between January and November, primarily attributed to dosage errors, amid concerns over the safety of compounded formulations of the drug.

Semaglutide, a glucagon-like peptide-1 receptor agonist or GLP-1 analog, gained approval from the Food and Drug Administration (FDA) in 2017.

The medicine is marketed as Ozempic for diabetes management and Wegovy for weight loss.

Folllow the link below to Medical News Today to read the full story:

- Advertisement -

https://www.medicalnewstoday.com/articles/what-happens-if-you-take-too-much-ozempic-or-wegovy

Information source: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

Latest news

- Advertisement -
Previous article
Why are cases of HIV infections on the rise among girls?
Next article
Dr. Pedro Mego’s Mission to Combat Peripheral Artery Disease to Save Limbs

More Articles

Mayo Clinic Unveils EHR‑Integrated AI to Personalize Prostate Cancer Education

Mayo Clinic researchers have developed and evaluated MedEduChat, an electronic health record (EHR) that works with a large language model to provide accurate, patient-specific prostate cancer education.  

AMA Backs Updated Dietary Guidelines, Commits to Advancing Nutrition in Medicine

“The American Medical Association (AMA) applauds the Administration’s new Dietary Guidelines for spotlighting the highly processed foods, sugar-sweetened beverages, and excess sodium that fuel heart disease, diabetes, obesity, and other chronic illnesses. The Guidelines affirm that food is medicine and offer clear direction patients and physicians can use to improve health."

Study Shows a Sharp Drop in Teen Wellness Visits During Transition to Adulthood

It’s common that as kids get to high school and transition to adulthood, they begin to skip yearly wellness visits with a pediatrician or other primary care provider.

Wegovy® Pill, First Oral GLP‑1 for Weight Loss, Now Available Nationwide

Wegovy® pill is now available, providing those seeking help with their weight the revolutionary science of GLP-1 medicine in a pill for the first time.
- Advertisement -

We feature articles about leading professionals in the medical and healthcare industry in the South Texas area. We are your connection to the medical community!

Pick up a copy of our publication on more than 800 locations Valley-wide.

Contact Us

Office (956) 928-1255

Sales (956) 451-4585

info@tbbmega.com

sales@tbbmega.com

Subscribe

© Mega Doctor News 2025

×